LIMA1 inhibits cisplatin resistance and malignant biological behavior of bladder cancer cells by suppressing the Wnt/β-catenin pathway
LIMA1 could inhibit the malignant biological behavior of BCa cells and weaken their cisplatin resistance by negatively regulating the Wnt/β-catenin signaling pathway. Our findings provide new insights for the clinical treatment of BCa.
Authors
- Huiying Wu (ORCID: https://orcid.org/0000-0001-6624-6773)
- Zhong Lv (ORCID: https://orcid.org/0000-0002-9674-5976)
- Shenglin Zhao (ORCID: https://orcid.org/0000-0001-9957-0473)
Institutions
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Changzhou No.2 People's Hospital (CN)
Publication Details
- Journal
- BMC Medical Genomics
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1186/s12920-025-02146-z
- Primary Topic
- Wnt/β-catenin signaling in development and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00